Enlivex Ltd. (ENLV)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (2)

NCT #TitlePhaseStatusEnrollment
NCT06233474 Study of Intra-articular Allocetra in Knee Osteoarthritis PHASE2 Active Not Recruiting 160
NCT06208241 Use of Allocetra-OTS in End Stage Knee Osteoarthritis - Assessment of Safety PHASE1 Active Not Recruiting 18

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis